Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy.

Ther Adv Med Oncol · 2021 · PMC8283058 · PMID 34345252

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

1 – 3 However, subgroup analysis of both trials showed a trend towards better outcomes in patients under 50 years of age. 1 The same benefit of adjuvant chemotherapy was reported in young premenopausal women and women under 50 years of age. 4 , 5 Moreover, early indication of NACT and response to a doxorubicin (A) and cyclophosphamide (C) regimen yielded b

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.